This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Montel, S. Articles by Bungener, C. PubMed PubMed Citation Articles by Montel, S. Articles by Bungener, C. Pubmed/NCBI databases Medline Plus Health Information Parkinson's Disease Patient Rights Social Bookmarking                         What's this?

Quality of Life in Relation to Mood, Coping Strategies, and Dyskinesia in Parkinson's Disease

Laboratory of Clinical Psychopathology and Neuropsychology, University of Paris Descartes, Boulogne Billancourt Paris, France, montel.sebastien{at}wanadoo.fr

Anne-Marie Bonnet, MD

Laboratory of Clinical Psychopathology and Neuropsychology, University of Paris Descartes, Boulogne Billancourt Paris, France

Catherine Bungener, PhD

Fédération des Maladies du Système nerveux de l'Hôpital La Pitié Salpêtrière, Paris, France

Given the variability of the results found in the literature, the current study is a step toward better clarifying the influence of motor and nonmotor factors on quality of life in Parkinson's disease. A total of 135 participants with Parkinson's disease were selected. Semistructured interviews were carried out, after which their mental and cognitive states were assessed using different scales (MINI, MADRS, EHD, HAMA). Finally, all participants completed 3 self-report questionnaires: 2 assessing coping strategies (WCC, CHIP) and 1, quality of life (Parkinson's disease questionnaire-39). It appears that the presence of dyskinesia, depression, and anxiety were linked to a poor quality of life. Interestingly, some different coping strategies, namely diversion as well as emotional strategies, were associated with a poor quality of life. These results encourage us to develop interventions focused on coping strategies and tailored to the emotional and clinical characteristics of each patient.

Key Words: coping strategies • dyskinesia • mood disorders • Parkinson's disease • quality of life

References

• Dodel RC, Berger K., Oertel WH Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias. Pharmacoeconomics. 2001;19:1013-1038.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Péchevis M., Clarke CE, Vieregge P., et al, and Trial Study Group. Effects of dyskinesias in Parkinson's disease on quality of life and health-related costs: a prospective European study. Eur J Neurol. 2005;12:956-963.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Gomez-Esteban JC, Zarranz JJ, Lezcano E., et al. Influence of motor symptoms upon the quality of life of patients with Parkinson's disease. Eur Neurol. 2007;57:161-165.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Woitalla D., Mueller T., Russ H., Hock K., Haeger DA The management approaches to dyskinesia vary from country to country. Neuroepidemiology. 2007;29:163-169.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• McDonald WM, Richard IH, Delong MR Prevalence, etiology, and treatment of depression in Parkinson's disease. Biol Psychiatry. 2003;54:363-375.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Samii A., Nutt JG, Ransom BR Parkinson's disease. Lancet. 2004;363:1783-1793.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Lieberman A. Depression in Parkinson's disease: a review. Acta Neurol Scand. 2006;113:1-8.[Web of Science][Medline] [Order article via Infotrieve]
• Hantz P., Caradoc-Davies G., Caradoc-Davies T., Weatherall M., Dixon G. Depression in Parkinson's disease. Am J Psychiatry. 1994;151:1010-1014.[Abstract/Free Full Text]
• Ranoux D. Depression and Parkinson'disease. Encephale. 2000;26:22-26.[Web of Science][Medline] [Order article via Infotrieve]
• Veazey C., Aki SO, Cook KF, Lai EC, Kunik ME Prevalence and treatment of depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2005;17:310-323.[Abstract/Free Full Text]
• Richard IH, Frank S., McDermott MP, et al. The ups and downs of Parkinson's disease: a prospective study mood and anxiety fluctuations. Cogn Behav Neurol. 2004;17: 201-207.[Medline] [Order article via Infotrieve]
• Menza MA, Robertson-Hoffman DE, Bonapace AS Parkinson's disease and anxiety: comorbidity with depression. Biol Psychiatry. 1993;34:465-470.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Lovatt B. An overview of quality of life assessments and outcome measures. Br J Med Econ. 1992;4:1-7.
• Slawek J., Derejko M., Lass P. Factors affecting the quality of life of patients with idiopathic Parkinson's disease-a cross-sectional study in an outpatient clinic attendees. Parkinsonism Relat Disord. 2005;11:465-468.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Lazarus R., Folkman S. 1984. Stress, appraisal and coping. New York: Springer.
• Endler NS, Parker JDA, Summerfelt LJ Coping with health problems: developing a reliable and valid multidimensional measure. Psychol Assess. 1998;10:195-205.[CrossRef][Web of Science]
• Frazier LD Coping with disease-related stressors in Parkinson's disease. Gerontologist. 2000;40:53-63.[Web of Science][Medline] [Order article via Infotrieve]
• Frazier LD Stability and change in patterns of coping with Parkinson's disease. Int J Aging Hum Dev. 2002;55: 207-231.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Schreurs KMG, De Ridder DTD, Bensing JM A one year study of coping, social support and quality of life in Parkinson's disease. Psychol Health. 2003;15:109-121.
• Backer JH Stressors, social support, coping, and health dysfunction in individuals with Parkinson's disease. J gerontol Nurs. 2000;26:6-16.[Medline] [Order article via Infotrieve]
• Montel S., Bungener C. Coping and quality of life in one hundred and thirty-five subjects with multiple sclerosis. Mult Scler. 2007;13:393-401.[Abstract/Free Full Text]
• Pucheu S., Consoli SM, D'Auzac C., Français P., Issad B. Do health causal attributions and coping strategies act as moderators of quality of life in peritoneal dialysis patients? J Psychosom Res. 2004;56:317-322.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Daniel SE, Lees AJ Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl. 1993;39:165-172.[Medline] [Order article via Infotrieve]
• Folstein MF, Folstein SE, Mc Hugh PR Mini mental scale: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12: 189-198.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hoehn M., Yahr M. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427-442.[Free Full Text]
• Fahn S., Elton R. Members of the UPDRS Development Committee. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson's Disease. Vol 2. Florham Park, NJ: Macmillan Health Care Information; 1987:153-163, 293-304.
• Lecrubier Y., Weiller E., Hergueta T., et al. M.I.N.I. 5.0.0., French Version, DSM-IV. Sheehan DV & Lecrubier Y. 1999.
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Revised (DSM IV-TR Washington, DC: American Psychiatric Association; 2000.
• Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Brit J Psychiatry. 1979;34:382-389.
• Jouvent R., Vindreau C., Montreuil M., Bungener C., Widlocher D. La clinique polydimensionnelle de l'humeur dépressive. Nouvelle version de l'EHD. Psychiatr Psychobiol. 1988;3:245-253.
• Bungener C., Jouvent R., Derouesné C. Affective disturbances in Alzheimer's disease. J Am Geriatric Soc. 1996; 44:1066-1071.[Web of Science][Medline] [Order article via Infotrieve]
• Bungener C., Jouvent R., Delaporte C. Psychopathological and emotional deficits in myotonic dystrophy. J Neurol Neurosurg Psychiatry. 1998;65:353-356.[Abstract/Free Full Text]
• Bungener C., Piquard A., Pradat PF Psychopathology in amyotrophic lateral sclerosis. A preliminary study with 27 ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord Other Motor Neuron Disord. 2005;6: 221-225.[CrossRef]
• Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50-55.[Web of Science][Medline] [Order article via Infotrieve]
• Pichot P., Pull CB, von Frenckell R., Pull MC Une analyse factorielle de l'échelle d'appréciation de l'anxiété de Hamilton. Psychiat Fennica (Int Edn) 1981:181-189.
• Vitaliano PP, Russo J., Carr JE, Maiuro RD, Becker J. The ways of coping check-list: revision and psychometric properties. Multivariate Behav Res. 1985;20:3-26.[CrossRef][Web of Science]
• Paulhan I., Nuissier J., Quintard B., Cousson F., Bourgeois M. La mesure du coping. Traduction et validation de la version Française de l'échelle Vitaliano. Ann Med Psychol. 1994;152:292-299.
• Jenkinson C., Peto V., Fitzpatrick R., et al. Self reported functioning and well-being in patients with Parkinson's disease: comparison of the short-form health survey (SF-36) and the Parkinson's disease questionnaire (PDQ-39. Age Ageing. 1995;24:505-509.[Abstract/Free Full Text]
• Peto V., Jenkinson C., Fitzpatrick R., Greenhall R. The development and validation of a short measure of functioning and wellbeing for individuals with Parkinson's disease. Qual Life Res. 1995;4:241-248.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Auquier P., Sapin C., Ziegler M., et al. Validation of the French language version of the Parkinson's disease questionnaire, PDQ-39. Rev Neurol. 2002;158:41-50.[Web of Science][Medline] [Order article via Infotrieve]
• Jenkinson C., Fitzpatrick R., Peto V., Greenhall R., Hyman N. The Parkinson's disease questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing. 1997;26: 353-357.[Abstract/Free Full Text]
• Muller T., Russ H. Levodopa, motor fluctuations and dyskinesia in Parkinson's disease. Expert Opin Pharmacother. 2006;7:1715-1730.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kuopio AM, Marttilla RJ, Helenius H. et al. The quality of life in Parkinson's disease. Mov Disord. 2000;15:216-223.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

This version was published on June 1, 2009

Journal of Geriatric Psychiatry and Neurology, Vol. 22, No. 2, 95-102 (2009)
DOI: 10.1177/0891988708328219


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Montel, S. Articles by Bungener, C. PubMed PubMed Citation Articles by Montel, S. Articles by Bungener, C. Pubmed/NCBI databases Medline Plus Health Information Parkinson's Disease Patient Rights Social Bookmarking                         What's this?